BRPI0715698B8 - produto, composição farmacêutica que o contém e uso de composto - Google Patents
produto, composição farmacêutica que o contém e uso de compostoInfo
- Publication number
- BRPI0715698B8 BRPI0715698B8 BRPI0715698A BRPI0715698A BRPI0715698B8 BR PI0715698 B8 BRPI0715698 B8 BR PI0715698B8 BR PI0715698 A BRPI0715698 A BR PI0715698A BR PI0715698 A BRPI0715698 A BR PI0715698A BR PI0715698 B8 BRPI0715698 B8 BR PI0715698B8
- Authority
- BR
- Brazil
- Prior art keywords
- compound
- product
- pharmaceutical composition
- composition containing
- pharmaceutically acceptable
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Vascular Medicine (AREA)
- Pulmonology (AREA)
- Gynecology & Obstetrics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
produto, composição farmacêutica que o contém e uso de composto a invenção refere-se a um produto que contém o composto da seguinte fórmula ( i) ou um sal farmaceuticamente aceitável deste composto, em combinação com pelo menos um composto dotado de propriedades inibidoras de pde5, ou um sal farmaceuticamente aceitável do mesmo, para uso terapêutico, simultaneamente, separadamente ou durante um período de tempo, no tratamento de uma enfermidade em que está envolvida vasoconstrição.
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IBPCT/IB06/052999 | 2006-08-29 | ||
IB2006052999 | 2006-08-29 | ||
IB2006053857 | 2006-10-19 | ||
IBPCT/IB06/053857 | 2006-10-19 | ||
PCT/IB2007/053448 WO2008026156A2 (en) | 2006-08-29 | 2007-08-28 | Therapeutic compositions comprising a specific endothelin receptor antagonist and a pde5 inhibitor |
Publications (3)
Publication Number | Publication Date |
---|---|
BRPI0715698A2 BRPI0715698A2 (pt) | 2013-08-06 |
BRPI0715698B1 BRPI0715698B1 (pt) | 2020-01-21 |
BRPI0715698B8 true BRPI0715698B8 (pt) | 2021-05-25 |
Family
ID=38954615
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0715698A BRPI0715698B8 (pt) | 2006-08-29 | 2007-08-28 | produto, composição farmacêutica que o contém e uso de composto |
Country Status (27)
Country | Link |
---|---|
US (8) | US8268847B2 (pt) |
EP (1) | EP2059246B1 (pt) |
JP (1) | JP5208113B2 (pt) |
KR (1) | KR101473022B1 (pt) |
CN (1) | CN101511365B (pt) |
AR (1) | AR062501A1 (pt) |
AU (1) | AU2007290099B2 (pt) |
BR (1) | BRPI0715698B8 (pt) |
CA (1) | CA2659770C (pt) |
CL (1) | CL2007002494A1 (pt) |
CY (1) | CY1114735T1 (pt) |
DK (1) | DK2059246T3 (pt) |
ES (1) | ES2438792T3 (pt) |
HK (1) | HK1133597A1 (pt) |
HR (1) | HRP20131233T1 (pt) |
IL (1) | IL197235A (pt) |
MA (1) | MA30704B1 (pt) |
MX (1) | MX2009002057A (pt) |
MY (1) | MY154591A (pt) |
NO (1) | NO342554B1 (pt) |
NZ (1) | NZ575702A (pt) |
PL (1) | PL2059246T3 (pt) |
PT (1) | PT2059246E (pt) |
RU (1) | RU2462249C2 (pt) |
SI (1) | SI2059246T1 (pt) |
TW (1) | TWI388556B (pt) |
WO (1) | WO2008026156A2 (pt) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2393117T3 (es) | 2005-09-12 | 2012-12-18 | Actelion Pharmaceuticals Ltd. | Composición farmacéutica estable que comprende una pirimidina-sulfamida |
MX2010001837A (es) | 2007-08-17 | 2010-03-10 | Actelion Pharmaceuticals Ltd | Derivados de 4-pirimidinasulfamida. |
AU2009215329B2 (en) * | 2008-02-20 | 2014-08-21 | Actelion Pharmaceuticals Ltd | Combination comprising paclitaxel for treating ovarian cancer |
CN102099026B (zh) | 2008-08-13 | 2012-08-29 | 埃科特莱茵药品有限公司 | 含美西特田的治疗组合物 |
TWI462739B (zh) * | 2010-11-02 | 2014-12-01 | Univ Kaohsiung Medical | Sildenafil-同族物四級銨哌嗪鹽類之製備及醫療用途 |
CN102949395A (zh) * | 2011-09-22 | 2013-03-06 | 荆志成 | 盐酸伐地那非片在制备治疗肺动脉高压药物中的应用 |
CN102839165B (zh) * | 2012-09-26 | 2014-12-10 | 金普诺安生物科技(苏州)有限公司 | 基因突变型重组蛋白酶k及其工业化生产方法 |
CN105693624B (zh) * | 2013-06-14 | 2018-05-18 | 杭州普晒医药科技有限公司 | 马西替坦晶体及其制备方法、其药物组合物和用途 |
KR20190030805A (ko) | 2017-09-14 | 2019-03-25 | 경상대학교산학협력단 | 폐고혈압 예방 또는 치료용 흡입제, 및 이의 투여방법 |
KR20210109558A (ko) | 2018-12-21 | 2021-09-06 | 액테리온 파마슈티칼 리미티드 | 폐동맥 고혈압의 치료를 위한 약제학적 조성물 |
TW202042818A (zh) | 2019-01-25 | 2020-12-01 | 瑞士商艾克泰聯製藥有限公司 | 用於治療慢性血栓性肺高血壓之醫藥組成物 |
Family Cites Families (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2801584A1 (de) * | 1978-01-14 | 1979-07-19 | Bayer Ag | Halogensubstituierte pyrimidin (2)yl-thiono-thiol-phosphor(phosphon)- saeureester, verfahren zu ihrer herstellung und ihre verwendung als insektizide und akarizide |
US5250534A (en) * | 1990-06-20 | 1993-10-05 | Pfizer Inc. | Pyrazolopyrimidinone antianginal agents |
RU2086544C1 (ru) * | 1991-06-13 | 1997-08-10 | Хоффманн-Ля Рош АГ | Бензолсульфонамидные производные пиримидина или их соли, фармацевтическая композиция для лечения заболеваний, связанных с активностью эндотелина |
TW394761B (en) | 1993-06-28 | 2000-06-21 | Hoffmann La Roche | Novel Sulfonylamino Pyrimidines |
US5589006A (en) * | 1993-11-30 | 1996-12-31 | Canon Kabushiki Kaisha | Solar battery module and passive solar system using same |
IL111959A (en) | 1993-12-17 | 2000-07-16 | Tanabe Seiyaku Co | N-(polysubstituted pyrimidin-4-yl) benzenesulfonamide derivatives their preparation and pharmaceutical compositions containing them |
GB9401090D0 (en) * | 1994-01-21 | 1994-03-16 | Glaxo Lab Sa | Chemical compounds |
WO1996016963A1 (de) | 1994-11-25 | 1996-06-06 | F. Hoffmann-La Roche Ag | Sulfonamide und deren verwendung als heilmittel |
TW313568B (pt) | 1994-12-20 | 1997-08-21 | Hoffmann La Roche | |
US5739333A (en) | 1995-05-16 | 1998-04-14 | Tanabe Seiyaku Co., Ltd. | Sulfonamide derivative and process for preparing the same |
DE69612874T2 (de) | 1995-12-20 | 2001-10-04 | Yamanouchi Pharma Co Ltd | Arylethensulfonamid-derivate und diese enthaltende medikamente |
PT1049695E (pt) | 1997-11-12 | 2002-07-31 | Bayer Ag | Imidazotriazinonas 2-fenil substituidas enquanto inibidores de fosfodiesterase |
US6087368A (en) * | 1998-06-08 | 2000-07-11 | Bristol-Myers Squibb Company | Quinazolinone inhibitors of cGMP phosphodiesterase |
KR100353014B1 (ko) | 1998-11-11 | 2002-09-18 | 동아제약 주식회사 | 발기부전 치료에 효과를 갖는 피라졸로피리미디논 화합물 |
TWI284642B (en) | 1999-01-18 | 2007-08-01 | Hoffmann La Roche | Novel heterocyclic sulfonamides |
HUP0201402A3 (en) | 1999-09-03 | 2003-12-29 | Actelion Pharmaceuticals Ltd | Bis-sulfonamides, process for their preparation and pharmaceutical compositions containing them |
TW200400821A (en) | 1999-11-02 | 2004-01-16 | Pfizer | Pharmaceutical composition (II) useful for treating or preventing pulmonary hypertension in a patient |
KR20020068373A (ko) | 1999-12-22 | 2002-08-27 | 액테리온 파마슈티칼 리미티드 | 부틴 디올 유도체 |
AU2001263850A1 (en) | 2000-04-20 | 2001-11-07 | Actelion Pharmaceuticals Ltd | Pyrimidine-sulfonamides having endothelin-antagonist activity |
WO2001081338A1 (en) | 2000-04-25 | 2001-11-01 | Actelion Pharmaceuticals Ltd | Substituted sulfonylaminopyrimidines |
IL155805A0 (en) * | 2000-12-18 | 2003-12-23 | Actelion Pharmaceuticals Ltd | Novel sulfamides and their use as endothelin receptor antagonists |
DE10148883A1 (de) * | 2001-10-04 | 2003-04-10 | Merck Patent Gmbh | Pyrimidinderivate |
US20060205733A1 (en) * | 2004-08-26 | 2006-09-14 | Encysive Pharmaceuticals | Endothelin a receptor antagonists in combination with phosphodiesterase 5 inhibitors and uses thereof |
US7094081B1 (en) * | 2005-03-24 | 2006-08-22 | Delphi Technologies, Inc. | Electrical connector assembly |
ES2393117T3 (es) * | 2005-09-12 | 2012-12-18 | Actelion Pharmaceuticals Ltd. | Composición farmacéutica estable que comprende una pirimidina-sulfamida |
US20100022568A1 (en) * | 2006-04-13 | 2010-01-28 | Actelion Pharmaceeuticals Ltd. | Endothelin receptor antagonists for early stage idiopathic pulmonary fibrosis |
-
2007
- 2007-08-23 AR ARP070103749A patent/AR062501A1/es not_active Application Discontinuation
- 2007-08-27 CL CL200702494A patent/CL2007002494A1/es unknown
- 2007-08-28 KR KR1020097005029A patent/KR101473022B1/ko active IP Right Grant
- 2007-08-28 MX MX2009002057A patent/MX2009002057A/es active IP Right Grant
- 2007-08-28 PL PL07826167T patent/PL2059246T3/pl unknown
- 2007-08-28 CA CA2659770A patent/CA2659770C/en active Active
- 2007-08-28 NZ NZ575702A patent/NZ575702A/en unknown
- 2007-08-28 TW TW096131928A patent/TWI388556B/zh active
- 2007-08-28 MY MYPI20090795A patent/MY154591A/en unknown
- 2007-08-28 SI SI200731367T patent/SI2059246T1/sl unknown
- 2007-08-28 ES ES07826167.4T patent/ES2438792T3/es active Active
- 2007-08-28 JP JP2009526239A patent/JP5208113B2/ja active Active
- 2007-08-28 EP EP07826167.4A patent/EP2059246B1/en active Active
- 2007-08-28 BR BRPI0715698A patent/BRPI0715698B8/pt active IP Right Grant
- 2007-08-28 PT PT78261674T patent/PT2059246E/pt unknown
- 2007-08-28 WO PCT/IB2007/053448 patent/WO2008026156A2/en active Application Filing
- 2007-08-28 RU RU2009111378/15A patent/RU2462249C2/ru active
- 2007-08-28 CN CN2007800321481A patent/CN101511365B/zh active Active
- 2007-08-28 AU AU2007290099A patent/AU2007290099B2/en active Active
- 2007-08-28 DK DK07826167.4T patent/DK2059246T3/da active
- 2007-08-28 US US12/439,290 patent/US8268847B2/en active Active
-
2009
- 2009-02-25 IL IL197235A patent/IL197235A/en active IP Right Grant
- 2009-03-06 MA MA31695A patent/MA30704B1/fr unknown
- 2009-03-26 NO NO20091254A patent/NO342554B1/no unknown
-
2010
- 2010-02-11 HK HK10101538.5A patent/HK1133597A1/xx unknown
-
2012
- 2012-09-05 US US13/604,148 patent/US20130210830A9/en not_active Abandoned
-
2013
- 2013-12-27 CY CY20131101163T patent/CY1114735T1/el unknown
- 2013-12-30 HR HRP20131233TT patent/HRP20131233T1/hr unknown
-
2014
- 2014-01-23 US US14/162,280 patent/US20140148460A1/en not_active Abandoned
-
2018
- 2018-01-26 US US15/881,060 patent/US20180147205A1/en not_active Abandoned
- 2018-11-16 US US16/193,859 patent/US20190083494A1/en not_active Abandoned
-
2019
- 2019-10-11 US US16/599,582 patent/US20200038401A1/en not_active Abandoned
-
2020
- 2020-07-30 US US16/942,895 patent/US20200352944A1/en not_active Abandoned
-
2021
- 2021-02-25 US US17/185,238 patent/US20210177849A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0715698B8 (pt) | produto, composição farmacêutica que o contém e uso de composto | |
ECSP088902A (es) | Derivados de pirazolo[3,4-d]-pirimidina utiles para tratar trastornos respiratorios | |
EA200802118A1 (ru) | Обладающие ингибирующей активностью в отношении mnk1/mnk2 тиенопиримидины, предназначенные для применения в фармацевтических композициях | |
MX341212B (es) | Inhibidor de bromodominio de benzodiazepina. | |
CY1116688T1 (el) | Τροποποιητες φαρμακοκινητικων ιδιοτητων θεραπευτικων ειδων | |
CL2007003520A1 (es) | Compuestos derivados de heterociclos sustituidos con morfolina, inhibidores de la actividad pi3 quinasa; composicion farmaceutica que comprende a dichos compuestos; kit farmaceutico; y su uso para el tratamiento profilactico o terapeutico del cancer. | |
IL195030A (en) | IV dpp inhibitor assemblies | |
BRPI0516483A (pt) | preparo e uso de derivados de ácido bifenil-4-il-carbonilamino para o tratamento de obesidade | |
ATE520668T1 (de) | Sigmarezeptor-inhibitoren | |
BR112015023412A8 (pt) | 3-pirimidin-4-il-oxazolidin-2-onas como inibidores de idh mutante, sua composição farmacêutica e seu uso. | |
CL2007003604A1 (es) | Composicion farmaceutica para administrar oral que comprende el compuesto 17-aminogeldanamicina amorfo; y su uso en el tratamiento del cancer. | |
GB0625648D0 (en) | Compounds | |
TNSN08444A1 (en) | Bicyclic derivatives as cetp inhibitors | |
BRPI0618479A2 (pt) | pirrolpiridinas composição farmacêutica que as contém | |
EA200801997A1 (ru) | Новые соединения | |
BRPI0606322A2 (pt) | formulações intravenosas de inibidores de pde-5 | |
MX2007004248A (es) | Derivados heterociclicos de bisarilurea sustituidos como inhibidores de cinasa. | |
CL2008000021A1 (es) | Compuestos derivados de 2,4-dianilinopirimidinas, inhibidores de proteinas cinasas; procedimiento de preparacion; composicion farmaceutica; y uso para el tratamiento o prevencion de enfermedades inflamatorias, diabetes y cancer. | |
HN2008001666A (es) | Derivados acidos de cicloalquilamino | |
MX2010007948A (es) | Inhibidores de proteinas de apoptosis. | |
EA200702282A1 (ru) | Комбинация феррохина и производного артемизинина для лечения малярии | |
BRPI0816798A2 (pt) | composto, composição farmacêutica, métodos para inibir a ação do glicogênio sintase cinase-3, e para tratar, prevenir ou melhorar uma doença, uso de um composto, e, artigo de fabricação | |
MA32841B1 (fr) | Composés de cycloundeca depsipeptides et leur utilisation comme médicament | |
WO2006108679A3 (en) | Substances and pharmaceutical compositions for the inhibition of glyoxalases and their use to combat cancer | |
BRPI0411347A (pt) | combinações terapêuticas compreendendo inibidores de pde e antagonistas dos receptores de vasopressina para o tratamanento de dismenorréia |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 21/01/2020, OBSERVADAS AS CONDICOES LEGAIS. |
|
B16C | Correction of notification of the grant [chapter 16.3 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 28/08/2007 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF |